Immunovant, Inc.

Q2 2026 13F Holders

Symbol
IMVT
CUSIP
45258J102
Type
Equity
Class
COM
Num filings
242
Total reported value, excl. options
$4.34 B
Manager Report Date Value ($000) Shares Option Type